Next-generation Alzheimer’s drug reduces risk of serious brain bleeds. A new kind of antibody drug that more efficiently enters the brain could slow the progression of Alzheimer's disease with a much lower risk of dangerous side effects than existing therapies
A apuração publicada por www.newscientist.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A new kind of antibody drug that more efficiently enters the brain could slow the progression of Alzheimer's disease with a much lower risk of dangerous side effects than existing therapies
- Ponto de atenção: next.
- Ponto de atenção: generation.
- Ponto de atenção: alzheimer.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Ciência.